Payden & Rygel Investment Group Abbott Laboratories Transaction History

Payden & Rygel Investment Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 08, 2024	BUY	$109.52 - $120.96 $2.29 Million - $2.53 Million	20,910 Added 18.57%	133,500 $15.2 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $2.29 Million - $2.53 Million	20,910 Added 18.57%	133,500 $15.2 Million
Q3 2023 Oct 08, 2024	BUY	$95.53 - $114.62 $10.8 Million - $12.9 Million	112,590 New	112,590 $10.9 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $10.8 Million - $12.9 Million	112,590 New	112,590 $10.9 Million

3,336

1.36B

10M

9.48M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

Stay updated on Payden & Rygel Investment Group with notifications on news.